Literature DB >> 31965607

Remodeling of the interstitial extracellular matrix in white matter multiple sclerosis lesions: Implications for remyelination (failure).

Jody M de Jong1, Peng Wang1, Michelle Oomkens1, Wia Baron1.   

Abstract

The extracellular matrix (ECM) provides protection, rigidity, and structure toward cells. It consists, among others, of a wide variety of glycoproteins and proteoglycans, which act together to produce a complex and dynamic environment, most relevant in transmembrane events. In the brain, the ECM occupies a notable proportion of its volume and maintains the homeostasis of central nervous system (CNS). In addition, remodeling of the ECM, that is transient changes in ECM proteins regulated by matrix metalloproteinases (MMPs), is an important process that modulates cell behavior upon injury, thereby facilitating recovery. Failure of ECM remodeling plays an important role in the pathogenesis of multiple sclerosis (MS), a neurodegenerative demyelinating disease of the CNS with an inflammatory response against protective myelin sheaths that surround axons. Remyelination of denuded axons improves the neuropathological conditions of MS, but this regeneration process fails over time, leading to chronic disease progression. In this review, we uncover abnormal ECM remodeling in MS lesions by discussing ECM remodeling in experimental demyelination models, that is when remyelination is successful, and compare alterations in ECM components to the ECM composition and MMP expression in the parenchyma of demyelinated MS lesions, that is when remyelination fails. Inter- and intralesional differences in ECM remodeling in the distinct white matter MS lesions are discussed in terms of consequences for oligodendrocyte behavior and remyelination (failure). Hence, the review will aid to understand how abnormal ECM remodeling contributes to remyelination failure in MS lesions and assists in developing therapeutic strategies to promote remyelination.
© 2020 The Authors. Journal of Neuroscience Research published by Wiley Periodicals, Inc.

Entities:  

Keywords:  extracellular matrix; matrix metalloproteinase; multiple sclerosis; oligodendrocyte; remyelination

Year:  2020        PMID: 31965607     DOI: 10.1002/jnr.24582

Source DB:  PubMed          Journal:  J Neurosci Res        ISSN: 0360-4012            Impact factor:   4.164


  15 in total

1.  Diffusion-derived parameters in lesions, peri-lesion and normal-appearing white matter in multiple sclerosis using tensor, kurtosis and fixel-based analysis.

Authors:  Chris Wj van der Weijden; Anouk van der Hoorn; Jan Hendrik Potze; Remco J Renken; Ronald Jh Borra; Rudi Ajo Dierckx; Ingomar W Gutmann; Hakim Ouaalam; Davood Karimi; Ali Gholipour; Simon K Warfield; Erik Fj de Vries; Jan F Meilof
Journal:  J Cereb Blood Flow Metab       Date:  2022-06-25       Impact factor: 6.960

Review 2.  Newly Identified Deficiencies in the Multiple Sclerosis Central Nervous System and Their Impact on the Remyelination Failure.

Authors:  Giuseppe Scalabrino
Journal:  Biomedicines       Date:  2022-03-30

3.  Phenotypic and genetic associations of quantitative magnetic susceptibility in UK Biobank brain imaging.

Authors:  Benjamin C Tendler; Karla L Miller; Chaoyue Wang; Aurea B Martins-Bach; Fidel Alfaro-Almagro; Gwenaëlle Douaud; Johannes C Klein; Alberto Llera; Cristiana Fiscone; Richard Bowtell; Lloyd T Elliott; Stephen M Smith
Journal:  Nat Neurosci       Date:  2022-05-23       Impact factor: 28.771

4.  Exercise rapidly alters proteomes in mice following spinal cord demyelination.

Authors:  Brian Mark Lozinski; Luiz Gustavo Nogueira de Almeida; Claudia Silva; Yifei Dong; Dennis Brown; Sameeksha Chopra; V Wee Yong; Antoine Dufour
Journal:  Sci Rep       Date:  2021-03-31       Impact factor: 4.379

Review 5.  Macroglial diversity: white and grey areas and relevance to remyelination.

Authors:  Inge L Werkman; Dennis H Lentferink; Wia Baron
Journal:  Cell Mol Life Sci       Date:  2020-07-09       Impact factor: 9.261

6.  Impairing committed cholesterol biosynthesis in white matter astrocytes, but not grey matter astrocytes, enhances in vitro myelination.

Authors:  Inge L Werkman; Janine Kövilein; Jenny C de Jonge; Wia Baron
Journal:  J Neurochem       Date:  2020-07-31       Impact factor: 5.372

7.  Identifying miRNAs in multiple sclerosis gray matter lesions that correlate with atrophy measures.

Authors:  Ajai Tripathi; Ishani Pandit; Aaron Perles; Yadi Zhou; Feixiong Cheng; Ranjan Dutta
Journal:  Ann Clin Transl Neurol       Date:  2021-05-12       Impact factor: 4.511

Review 8.  New Epidermal-Growth-Factor-Related Insights Into the Pathogenesis of Multiple Sclerosis: Is It Also Epistemology?

Authors:  Giuseppe Scalabrino
Journal:  Front Neurol       Date:  2021-11-26       Impact factor: 4.003

Review 9.  Matrix Metalloproteinase-9 as an Important Contributor to the Pathophysiology of Depression.

Authors:  Hongmin Li; Zhaofu Sheng; Suliman Khan; Ruiyi Zhang; Yang Liu; Yan Zhang; V Wee Yong; Mengzhou Xue
Journal:  Front Neurol       Date:  2022-03-18       Impact factor: 4.003

10.  Distinct gene expression in demyelinated white and grey matter areas of patients with multiple sclerosis.

Authors:  Thecla A van Wageningen; Emma Gerrits; Nieske Brouwer; John J P Brevé; Jeroen J G Geurts; Bart J L Eggen; H W G M Erik Boddeke; Anne-Marie van Dam
Journal:  Brain Commun       Date:  2022-01-17
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.